News Headlines

  1. HALIX Starts Operational Production With New cGMP Facility In Q4-2019

    HALIX, a contract development and manufacturing organization of clinical and commercial proteins and viral products, based in the Netherlands, announced today that they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.

  2. Cambrex To Be Acquired By The Permira Funds For $60.00 Per Share In Cash

    Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.

  3. New Partnership Will Advance Three Antibacterial Programmes As Part Of The Innovative Medicines Initiative (IMI), A Public-Private European R&D Consortium

    Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents recently: Gram-Negative Antibacterials NOW ("GNA NOW").

  4. ACG Acquires Pharma Processing Equipment Provider Xertecs GmbH

    ACG Engineering (ACGE) – part of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry – has acquired Germany-based pharma processing equipment company, Xertecs GmbH.

  5. Ardena Group launches Life Science Ingredients Arm

    Contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.

  6. Fujifilm Completes Acquisition Of Biogen’s Manufacturing Site In Denmark

    FUJIFILM Corporation (“Fujifilm”) recently announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark (“Hillerød Manufacturing”) from Biogen. Fujifilm invested approximately US$890M in cash for the transaction.

  7. NIIMBL And FDA Sign Agreement To Support Innovation In Biopharma Manufacturing

    The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA).

  8. Samsung BioLogics And UCB Sign Third Drug Manufacturing Deal

    Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB’s anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals

  9. CDMO LSNE Announces Expansion Of Controlled Temperature Storage Services

    Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization, continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire.

  10. New Analysis Notes The Critical And Evolving Role Pharmaceutical Distributors Play In U.S. Healthcare

    A new report published by the Healthcare Distribution Alliance (HDA) and Deloitte Consulting LLP highlights the value distributors provide to the United States healthcare ecosystem and estimates pharmaceutical distributors generate between $33 and $53B in cost savings annually.